Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
PaperCitations, authors & open-access status
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 741 citations, 2021 year and hybrid oa status.
741
Citations
2021
Year
hybrid
OA Status